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Early and rapid engraftment of bone marrow-derived microglia
in scrapie
Abstract
Prion neuroinvasion is accompanied by maximal activation of microglia, the significance of which for
pathogenesis is unknown. Here, we used bone marrow (BM) cells expressing GFP (green fluorescent
protein) to study the turnover of microglia in mouse scrapie. We found that >or=50% of all brain
microglia were replaced by BM-derived cells before clinical disease onset. In terminally sick mice,
microglia density increased threefold to fourfold. Hence BM-derived microglia rapidly and efficaciously
colonize the brain in scrapie. Whereas reconstitution of wild-type mice with prion protein-deficient
(Prnp(o/o)) BM did not alter scrapie pathogenesis, Prnp(o/o) mice transplanted with wild-type BM cells
were resistant to peripherally administered prions despite high levels of infectivity in the spleen.
Cerebellar homogenates from prion-inoculated Prnp(o/o) mice reconstituted with >10% of wild-type
microglia failed to infect transgenic mice overexpressing the cellular prion protein. Hence, in contrast to
previous reports, microglia are not competent for efficient prion transport and replication in vivo.
Neurobiology of Disease
Early and Rapid Engraftment of Bone Marrow-Derived
Microglia in Scrapie
Josef Priller,1,2* Marco Prinz,1,3* Mathias Heikenwalder,1* Nicolas Zeller,1 Petra Schwarz,1 Frank L. Heppner,1 and
Adriano Aguzzi1
1Institute of Neuropathology, Department of Pathology, University of Zurich, 8091 Zurich, Switzerland, 2Departments of Psychiatry and Experimental
Neurology, Charite´-Universita¨tsmedizin Berlin, 10117 Berlin, Germany, and 3Institute of Neuropathology, University of Go¨ttingen, 37075 Go¨ttingen,
Germany
Prionneuroinvasion is accompaniedbymaximal activationofmicroglia, the significance ofwhich for pathogenesis is unknown.Here,we
used bonemarrow (BM) cells expressing GFP (green fluorescent protein) to study the turnover of microglia inmouse scrapie. We found
that 50% of all brain microglia were replaced by BM-derived cells before clinical disease onset. In terminally sick mice, microglia
density increased threefold to fourfold. Hence BM-derived microglia rapidly and efficaciously colonize the brain in scrapie. Whereas
reconstitution of wild-typemicewith prion protein-deficient (Prnpo/o) BMdid not alter scrapie pathogenesis,Prnpo/omice transplanted
with wild-type BM cells were resistant to peripherally administered prions despite high levels of infectivity in the spleen. Cerebellar
homogenates from prion-inoculated Prnpo/o mice reconstituted with 10% of wild-type microglia failed to infect transgenic mice
overexpressing the cellularprionprotein.Hence, in contrast toprevious reports,microglia arenot competent for efficientprion transport
and replication in vivo.
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Introduction
Scrapie, chronic wasting disease, and bovine spongiform enceph-
alopathy (BSE), as well as Kuru, iatrogenic and variant
Creutzfeldt–Jakob disease (CJD) are fatal neurodegenerative dis-
orders caused by peripheral uptake of prions. After peripheral
infection, prions primarily replicate in lymphoid follicles (Aguzzi
and Sigurdson, 2004; Aguzzi andHeikenwalder, 2005). The caus-
ative agent is thought to be PrPSc, a pathological conformer of the
cellular prion protein, PrPC (Prusiner, 1982; Aguzzi and Poly-
menidou, 2004). Follicular dendritic cells (FDCs), located in ger-
minal centers of lymphoid organs, are a major site of peripheral
PrPSc accumulation (Kitamoto et al., 1991; Brown et al., 1999;
Mabbott et al., 2000; Montrasio et al., 2000). Other, as yet poorly
defined, immune cells may also replicate the infectious agent in
lymphoreticular tissues (Oldstone et al. 2002; Prinz et al., 2002).
Despite prion colonization of peripheral sites, only the CNS
shows evident histopathological damage as a result of infection,
characterized by vacuolation, neuronal cell loss, and gliosis (Mas-
ters and Richardson, 1978). Prion neuroinvasion is thought to
occur through sympathetic nerve endings (Glatzel et al., 2001),
and the relative distance between FDCs and sympathetic nerves
was shown to control the process of neuroinvasion (Prinz et al.,
2003). However, the mechanism of transfer of the infectious
agent from FDCs to hot spots of innervation and the CNS re-
mains enigmatic (Aguzzi and Heikenwalder, 2005).
Macrophages/microglia may play a role in the dispersion and
replication of pathological prion protein. In CJD and scrapie,
microglial activation parallels the temporal and spatial pattern of
PrPSc deposition and precedes neuronal cell loss and clinical dis-
ease (Manuelidis et al., 1997; Williams et al., 1997; Andre´oletti et
al., 2002b; Hughes et al., 2002). Depending on the agent strain–
host combination,microglial activation can precede or follow the
accumulation of pathological prion protein (Baker et al., 1999).
Perivascular macrophages and microglia express PrPC in vivo
(Esiri et al., 2002), and PrPSc was detected in microglia from
Kuru-, CJD-, BSE-, and scrapie-affected brains (Miyazono et al.,
1991; Guiroy et al., 1994; Andre´oletti et al., 2002a; Gonza´lez et al.,
2005; Kova´cs et al., 2005).
Neurons and astrocytes respond to prion infection by attract-
ingmicroglia through fractalkine receptor and chemokine recep-
tor 5 (CCR5) activation in vitro (Hughes et al., 2002; Marella and
Chabry, 2004; Lee et al., 2005). Activated glial cells fromCJD- and
scrapie-infected brains express proinflammatory cytokines, in-
cluding interleukin (IL)-1, C1q complement, and cathepsin S
(Dandoy-Dron et al., 1998; Baker andManuelidis, 2003). Mono-
cytes are recruited into end-stage scrapie-affected brains in a par-
adigm of intracerebral prion inoculation (Williams et al., 1995),
but the kinetics of myeloid cell recruitment into the CNS after
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peripheral prion inoculation remains unknown. As gene thera-
pies against prions are emerging (Heppner et al., 2001; Mallucci
et al., 2003; Meier et al., 2003; Aguzzi and Sigurdson, 2004; Do-
nofrio et al., 2005), targeting of genetically modified cells to the
CNSmay become instrumental. Here, we explored the possibility
that migratory myeloid cells might sense pathological changes in
the murine brain after peripheral prion challenge.We found that
bone marrow (BM)-derived microglia engraft rapidly and effica-
ciously in the scrapie-affected brain before the onset of clinical
symptoms and coincident with the upregulation of proinflam-
matory cytokines and chemokines. Surprisingly, no scrapie infec-
tivity was isolated from the engrafted microglia, suggesting (at
variance from previous reports) that microglia in vivo lack the
intrinsic machinery for efficient prion replication.
Materials andMethods
Retroviral transduction of hematopoietic cells and bone marrow transplan-
tation. All animals were maintained under specific pathogen-free condi-
tions according to the legislation of the veterinarian office of the Kanton
Zurich, Switzerland. Eight- to 12-week-old wild-type (wt: 129SvBL/6)
and Prnpo/o mice from the breeding facility of the University of Zurich,
Labortierkunde, were transplanted with BM cells that were transduced
with a murine stem cell virus (MSCV)-based retroviral vector encoding
enhanced green fluorescent protein (GFP) driven by its long terminal re-
peat (Persons et al., 1997; Priller et al., 2001a,b). The MGirL22YMSCV-
based vector was generated by replacing the neomycin coding cassette in
MSCVNEO2.1 (Hawley et al., 1994) with an internal ribosomal entry site
from the encephalomyocarditis virus linked to a gene encoding amutant
dihydrofolate reductase (L22Y). The enhanced GFP gene from EGFP-1
(Clontech, Palo Alto, CA) was cloned into the resulting plasmid up-
stream of the internal ribosomal entry site. High-titer, ecotropic
MGirL22Y virus producer cells were generated by transduction of GP
plus E86 cells with MGirL22Y vector particles derived by cotransfection
of 293T cells with the plasmid containing theMGirL22Y sequences and a
helper plasmid encoding the required gag, pol, and env retroviral genes
(Persons et al., 1997). The presence of replication-competent retrovirus
from the MGirL22Y virus-producer cells was ruled out by testing the
ability of conditionedmedium from the virus producer cells tomobilize,
in amus dunni test cell line, a recombinant, integratedMoloney leukemia
virus (G1Na) that encodes for neomycin phosphotransferase (McLachlin
et al., 1993). Conditioned medium from the MGirL22Y virus producer
cells was used to infectmus dunni cells harboring two integrated copies of
G1Na (provided by Dr. E. F. Vanin, St. Jude’s Children’s Research Hos-
pital, Memphis, TN). The transducedmus dunni cells were cultured for 3
weeks, and conditionedmediumwas taken from these cells and tested on
naive mus dunni cells for the ability to confer neomycin resistance. No
neomycin-resistant colonies were ever detected over multiple indepen-
dent assays.
Whole BM cells were obtained from femurs and tibias of adult wild-
type and Prnpo/o mice treated with 150 mg/kg 5-fluoruracil (Sigma,
Deisenhofen, Germany) for 3 d. After stimulation with 20 ng/ml IL-3, 50
ng/ml IL-6, and 50 ng/ml stem cell factor (R & D Systems, Abingdon,
UK), adherent and nonadherent whole BM cells were cocultured with
irradiated (1300 cGy) GPE86 virus producer cells. After 48 h of viral
transduction, nonadherent BM cells were obtained from the cocultures,
washed with PBS, counted in Tu¨rk solution, and transplanted into le-
thally irradiated (1100 cGy) wt or Prnpo/omice by tail vein injection (5
106 unsorted cells/mouse). For in vitro clonogenic progenitor assays,
transduced BM cells were suspended in 2 ml of methylcellulose supple-
mented with IL-3, IL-6, and stem cell factor (Stem Cell Technologies,
Vancouver, British Columbia, Canada), and analyzed after 7–10 d of
incubation.
Flow cytometric analysis of GFP expression in peripheral blood leuko-
cytes. Fifteen weeks after bone marrow transplantation (BMT), periph-
eral blood was obtained from the retro-orbital sinus of methoxyflurane-
anesthetizedmice and examined by FACS (BectonDickinson,Mountain
View, CA). After erythrocyte lysis using FACS lysis solution (Becton
Dickinson), cells were incubated with CD11b-PE (4 g/ml; BD Pharm-
ingen, San Diego, CA) at 4°C for 45 min. After sequential washing steps
with FACS buffer containing 5% fetal calf serum (FCS) and 5mM EDTA,
living cells were analyzed on a Becton Dickinson FACSCalibur. Myeloid
cells were gated based on their forward- and side-scatter profile, and
analyzed for GFP and CD11b expression. Data were evaluated using the
CellQuest software.
Inoculation of mice.One week after FACS analysis, chimeric mice were
inoculated intraperitoneally with 100l of brain homogenate containing
6 log LD50 units of the RockyMountain Laboratory scrapie strain passage
5 (RML5) as described previously (Kaeser et al., 2001).
Mice were monitored every second day, and scrapie was diagnosed
according to clinical criteria (ataxia, kyphosis, priapism, and parapare-
sis). Mice were killed on the day of onset of terminal signs of scrapie.
Attack rate is defined as the percentage of chimeras succumbing to spon-
giform encephalopathy. Disease latency is expressed in days (means 
SD).
Glial cell cultures. Primary microglial and astroglial cell cultures were
prepared from newborn C57BL/6 mice obtained from the breeding fa-
cility of the University of Zurich as described previously (Nolte et al.,
1996). Cortical tissue was freed of meninges, trypsinized, and carefully
dissociated. The cortical cells were cultured in DMEM supplemented
with heat-inactivated 10% fetal calf serum (Biochrom, Berlin, Germany).
After 9–12 d, microglia were separated from the underlying astrocyte
monolayer by gentle agitation. An immortalized murine microglial cell
line, BV-2 (Bocchini et al., 1992), was cultured in DMEM containing 5%
FCS.
Infectivity bioassays. tga20mice (Fischer et al., 1996) from the breeding
facility of the University of Zurich were inoculated intracerebrally with
1% (w/v) cerebellum or spleen homogenates from chimeric mice. Tis-
sues were homogenized in 0.32 M sucrose (10%homogenates).When the
solution appeared homogenous, it was centrifuged at 500 g for 5 min.
The supernatants were diluted to 1% in PBS containing sterile 5%bovine
serum albumin. Supernatants (30 l) were inoculated intracerebrally
into groups of four tga20 mice. Infectivity titers were determined using
the relationship y  11.45  0.088x ( y, log LD50/milliliter of homoge-
nate; x, incubation time in days until terminal disease) derived from the
method of Prusiner et al. (1982).
PrP affinity assay and immunoblot analysis. Immunoaffinity purifica-
tion and immunoblot analysis were performed on tissue homogenates
and glial cell lysates as described previously (Prinz and Hanisch, 1999;
Fischer et al., 2000). Cells were lysed on ice in 20 mM Tris-HCl, pH 7.3,
containing 140 mM sodium chloride, 0.5% Triton X-100, 2 mM sodium
orthovanadate, and one tablet per 50 ml Complete protease inhibitors
(Boehringer Mannheim, Mannheim, Germany). Minced brain tissue
(10% w/v) was homogenized in PBS containing 0.5% NP-40 and 0.5%
sodium deoxycholate. Extracts were cleared by centrifugation. Superna-
tants were adjusted to 5 mg/ml protein and treated with 50 g/ml pro-
teinase K or PBS at 37°C for 30 min. Tosyl-activated paramagnetic beads
(Dynal, Oslo, Norway) were covalently coupled to mouse serum pro-
teins and preincubated in PBS containing 3% NP-40 and 3% Tween
20. After incubation with lysates at 37°C for 30 min, beads were
washed in PBS and collected using a magnetic particle concentrator.
All samples were heated to 95°C for 5 min after addition of 100 mM
phenylmethyl sulfonyl fluoride (Merck, Dietikon, Switzerland) and
loading buffer. Fifty micrograms of total protein per sample with or
without proteinase K treatment were electrophoresed through a 12%
SDS-polyacrylamide gel and blotted onto nitrocellulose. After block-
ing with Tris-buffered saline-Tween (TBS-T) containing 5% nonfat
milk, membranes were incubated with monoclonal antibody
ICSM-18 (1:20,000; generously provided by Dr. J. Collinge, Institute
of Neurology, Queen Square, UK) for 1 h, washed in TBS-T and
developed by enhanced chemiluminescence (Amersham Biosciences,
Little Chalfont, UK).
TaqMan analysis of cytokine, chemokine, and chemokine receptor gene
expression. Total RNA was isolated from whole brain or cerebellum of
chimeric mice at 0, 100, and 150 d postinoculation (dpi) and terminal
disease using TRI Reagent (Invitrogen, San Diego, CA) according to the
manufacturer’s protocol. Purified total RNA (1 g) was used for the
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generation of cDNAwith theQuantiTect kit (Qiagen,Hilden,Germany).
TaqMan analysis of the cDNA samples was performed in a thermal cycler
(7900HT Fast Real-Time PCR System; Applied Biosystems, Rotkreuz,
Switzerland) with a primary incubation step of 2 min at 50°C and dena-
turation for 10 min at 95°C, followed by 40 cycles of 95°C for 15 s and 1
min elongation at 60°C. For normalization, mouse -actin or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA content
was determined in a separate reaction on identical plates. To ensure for
the specificity of the products, selected samples were separated on 1%
agarose gels and visualized with ethidium bromide under UV illumina-
tion. The following primer sets were used: interferon (IFN)-, forward
primer, 5-TGA ACG CTA CAC ACT GCA TCT TGG-3, and reverse
primer, 5-CGA CTC CTT TTC CGC TTC CTG AG-3; GAPDH, for-
ward primer, 5-CCA CCC CAG CAA GGA CAC T-3, and reverse
primer, 5-GAA ATT GTG AGGGAG ATG CTC AGT-3; tumor necro-
sis factor (TNF), forward primer, 5-CAT CTT CTC AAA ATT CGA
GTGACA A-3, and reverse primer, 5-TGGGAG TAGACA AGG TAC
AAC CC-3; actin, forward primer, 5-ACC TTC AAC ACC CCA GCC
ATG-3, and reverse primer, 5-GGCCATCTCTTGCTCGAAGTC-3;
regulated on activation normal T cell expressed and secreted (RANTES)/
CCL5, forward primer, 5-TTTGCCTACCTCTCCCTAGAGCTG-3,
and reverse primer, 5-ATG CCG ATT TTC CCA GGA CC-3; CCR1,
forward primer, 5-TTT TAA GGC CCA GTG GGA GTT CAC TCA
CCG-3, and reverse primer, 5-TGG TAT AGC CAC ATG CCT TTG
AAA CAG CTG C-3; CCR3, forward primer, 5-CTG CTA CAC AGG
AAT CAT CAA AAC-3, and reverse primer, 5-GTT CTT TCC ATT
TTC TCA CCA GGA AG-3; CCR5, forward primer, 5-TAC CAG ATC
TCA GAA AGA AGG TTT TCA TTA-3, and reverse primer, 5-GCG
TTT GAC CAT GTG TTT TCG GAA GAA CAC T-3; CX3CL1 (fractal-
kine), forward primer, 5-GGG TGG CCA TGT TTG CTT AC-3, and
reverse primer, 5-CAGGCAAGCAGCTCACACTG-3. TaqMan gene
expression assays (Applied Biosystems) were used according to theman-
ufacturer’s manuals for CXCL9 [monokine induced by IFN- (MIG)],
ID Mm00434946_m1; CXCL2 [growth-related oncogene  (GRO-)],
ID Mm00436450_m1; CXCL10 [IFN--inducible protein (IP-10)], ID
Mm00445235_m1; and CCL2 [monocyte chemoattractant protein 1
(MCP-1)], ID Mm00441242_m1.
Immunohistochemical analysis. After transcardial perfusion with 4%
paraformaldehyde, 10–20 m cryosections were obtained from the
brains. Sections were stained with hematoxylin and eosin for evaluation
of neuropathological changes. Adjacent sections were selected for immu-
nohistochemistry and were incubated in PBS containing 10% normal
goat serum and 0.5%TritonX-100. Primary antibodies were added over-
night at a concentration of 5 g/ml for Iba1 (Waco, Osaka, Japan), 5.8
g/ml for GFAP (DakoCytomation, Glostrup, Denmark), 2 g/ml for
MAP-2 (microtubule-associated protein 2) (Sigma), 1:25 for major
histocompatibility complex (MHC) class II (Serotec, Oxford, UK),
2.5 g/ml for 2G11 (generously provided by Dr. P. Berthon, INRA,
Nouzilly, France), 1 g/ml for scrapie-associated fibrils (SAF)-84
(SpiBio, Massy, France), 4 g/ml for clone POM-1 (Polymenidou et
al., 2005), and 1 g/ml for Ki-67/Tec-3 (DakoCytomation). Texas
Red- or Alexa 546-conjugated secondary antibodies (Invitrogen)
were added at a concentration of 10 g/ml for 1 h. For IgG staining,
sections were incubated in PBS containing 10% normal goat serum
and treated with 0.3% H2O2 for 10 min. A biotinylated goat anti-
mouse IgG antibody (Chemicon, Temecula, CA) was added at a con-
centration of 2 g/ml for 90 min, followed by visualization of binding
using avidin–biotin–peroxidase complex (DakoCytomation) and
3,3-diaminobenzidine/H2O2 (Walter, Kiel, Germany). Sections were
counterstained with hematoxylin. The specificity of all stainings was
controlled by omission of primary antibodies. Nuclei were counter-
stained with 4,6-diamidino-2-phenylindole (DAPI) at a concentra-
tion of 10 M (Invitrogen). Sections were coverslipped using
DakoCytomation Fluorescent Mounting Medium.
Analysis was performed using a conventional fluorescencemicroscope
equipped with a color scanner (Zeiss, Oberkochen, Germany) and a
confocal laser-scanning microscope (Leica, Nussloch, Germany). Re-
gional microglia engraftment was quantified by two independent inves-
tigators who counted the number of GFP-expressing cells among all
Iba1-immunoreactive microglia per 0.31 mm2 [two to seven randomly
selected visual fields at 0, 100, 150, 300 dpi and terminal disease in four
different regions of the brain including frontal cortex, brainstem, hip-
pocampus, and cerebellum from the following chimeric mice: wt3wt
(n 6), wt3ko (n 4), and ko3ko (n 4)]. An unpaired Student’s t
test, ANOVA with Dunnett’s post hoc test and rank-based ANOVA with
Dunn’s test were performed for statistical evaluation of the data. Signif-
icance was accepted for p 0.05.
Results
Reconstitution of hematopoiesis with GFP-expressing
peripheral blood cell progeny
BM cells from adult wild-type (wt) and Prnpo/o mice were cul-
tured on viral producer cells. Clonogenic progenitor assays re-
vealed that hematopoietic progenitors were successfully trans-
duced with the retrovirus encoding GFP (Fig. 1A). Four types of
BM chimeric mice (n 92) were generated in this study: wtmice
Figure 1. Reconstitution of hematopoiesis with GFP-marked peripheral blood cell progeny.
A, BM cellswere transducedwith amurine stem cell virus-based retroviral vector encodingGFP.
Cells were subsequently plated in methylcellulose supplemented with hematopoietic growth
factors. After 6 d in culture, GFP-transduced hematopoietic colonies were visualized under
fluorescencemicroscopy.B, Fifteenweeks after transplantationofGFP-transducedBMcells into
lethally irradiated mice, myeloid cells were gated based on their forward-scatter (FSC) and
side-scatter (SSC) profile. C, Flow cytometry of GFP expression in peripheral bloodmononuclear
cells revealed that99%of CD11b cells expressed GFP in a representativewt3wt chimera
(bottom). For comparison, no GFP expression was detected in peripheral blood mononuclear
cells from a nontransplanted wt mouse (top).
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transplanted with BM from wt mice
(wt3wt), wt mice transplanted with BM
fromPrnpo/omice (ko3wt),Prnpo/omice
transplanted with BM from wt mice
(wt3ko), and Prnpo/o mice transplanted
with BM from Prnpo/omice (ko3ko). Fif-
teen weeks after transplantation of the
GFP-transduced BM cells into lethally ir-
radiated recipientmice, the percentages in
GFP-marking of peripheral blood
CD11b monocytes were analyzed (Fig.
1B,C): wt3wt, 96  4%; ko3wt, 98 
2%; wt3ko, 95 5%; ko3ko, 99 1%.
Peripheral and central prion
pathogenesis in chimeric mice
To investigate peripheral and central
prion pathogenesis, the four different
groups of chimeric mice were inoculated
intraperitoneally with 6 log LD50 RML5.
wt recipient mice succumbed to scrapie
	190 dpi, regardless of whether they
had been reconstituted with GFP-
expressing BM cells from wt mice (at-
tack rate, 5/5; disease latency, 191 6 d)
or from Prnp o/o mice (attack rate, 5/5;
disease latency, 189  3 d). In contrast,
none of the wt3ko (n  5) or ko3ko
(n  6) GFP-chimeras developed
scrapie at 300 dpi. Susceptibility to
scrapie and disease progression was not
different in mice that received BMT
compared with nontransplanted wt and
Prnp o/o mice [for comparison, see Prinz
et al. (2002): wt attack rate, 12/12; wt
disease latency, 203  11 d; Prnp o/o
attack rate, 0/6].
Spatiotemporal kinetics of microglia engraftment in BM
chimeras after peripheral prion inoculation
Transplantation of GFP-marked BM cells resulted in the engraft-
ment of ramified GFP-expressing microglia in the brains of wt
and Prnpo/omice (Figs. 2-5). These cells expressed themonocyte/
macrophage marker, Iba1 (Fig. 2A–C). At the time of intraperi-
toneal prion inoculation (i.e., 16 weeks post-BMT), on average
10% of the microglia expressed GFP in cortex (42 GFPmicro-
glia/mm2), hippocampus (39 GFP microglia/mm2), cerebel-
lum (61 GFP microglia/mm2), and brainstem (32 GFP mi-
croglia/mm2) (Figs. 2A–C, 3). At 100 dpi, the level of microglia
engraftment was 6.5% in cortex (30 GFP microglia/mm2),
18.5% in hippocampus (70 GFPmicroglia/mm2), 13% in cer-
ebellum (55 GFPmicroglia/mm2), and 15.5% in brainstem (61
GFPmicroglia/mm2) (Figs. 2A–C, 3). Iba1microglia showed
an activatedmorphology at 100 dpi, although no obvious signs of
brain damage were observed between 0 and 150 dpi (Fig. 4H)
(data not shown) and PrPSc was undetectable in the brain (Fig.
5A). At the time of the first deposition of PrPSc in wt3wtmice at
150 dpi as demonstrated by immunoblot (Fig. 5A) and histoblot
(data not shown), a dramatic increase in the number of GFP-
expressing microglia was observed throughout the brain (Fig.
2A–C). Although the total number of microglia remained un-
changed (Fig. 3), on average 44% of the microglia in cortex were
BM-derived (156GFPmicroglia/mm2), 73.5% of themicroglia
in hippocampus (212 GFPmicroglia/mm2), 50% of the micro-
glia in cerebellum (141 GFP microglia/mm2), and 50% of the
microglia in brainstem (245 GFP microglia/mm2), suggesting
thatmyeloid cells were actively recruited into the brain during the
course of disease to replace endogenous microglial cells. No ap-
Figure 2. Engraftment of BM-derived microglia after intraperitoneal prion inoculation. Wild-type mice transplanted with
GFP-transducedBMcellswere inoculated intraperitoneallywith scrapie prions at 15weeks post-BMT.A, Representative cerebellar
sections of chimericmice reveal engraftment of GFPBM-derived cells at the time of prion inoculation (0d), 100 and 150 dpi, and
in terminal stages of scrapie (term.). B, Immunohistochemical staining of the same sections for the monocyte/macrophage
marker, Iba1 (red), reveals enhanced engraftment of BM-derived microglia at 150 d, and microglia proliferation in terminally ill
mice (C, overlay of images inAandB).D, Representative cerebellar sectionof a komouse transplantedwithGFP-transducedwtBM
cells (wt3ko) at 160 dpi. E, Representative cerebellar section of a terminally ill wt mouse transplanted with GFP-transduced ko
BM cells (ko3wt) reveals engraftment of GFP BM-derivedmicroglia and substantial astrogliosis (red, GFAP immunoreactivity;
blue, DAPI staining of nuclei). G, Overlay of the images in E. Scale bars: A–C, 100m; F, G, 25m.
Figure3. Semiquantitative analysis of regionalmicroglia engraftment at various times after
intraperitoneal prion inoculation. The numbers of Iba1 microglia (white bars) and
GFPIba1 BM-derived microglia (gray bars) were determined in representative sections
frombrainstem (A), cerebellum (B), hippocampus (C), and frontal cortex (D) of chimericmice at
0–300 dpi and in terminal stages of scrapie (term.). Data are expressed as microglial cells per
square millimeter (means SD). Note the significant increase in BM-derived microglia at 150
dpi inwt3wtcomparedwithwt3koandko3komice ( p0.05).Moreover, thenumberof
microglia, including BM-derived microglia, was significantly increased in terminal (term.)
wt3wt comparedwithwt3wtmice at 150 dpi ( p 0.05) andwt3ko and ko3komice at
300 dpi ( p 0.05). The number of cerebellarmicrogliawas significantly decreased inwt3ko
and ko3ko mice at 300 dpi compared with 150 dpi ( p 0.01).
11756 • J. Neurosci., November 8, 2006 • 26(45):11753–11762 Priller et al. •Microglia Engraftment in Murine Scrapie
parent disruption of the blood–brain barrier (BBB)was observed
at 0, 100, 150 dpi and even in terminal stages of disease, as dem-
onstrated by the absence of Ig extravasation (Fig. 4G). Interest-
ingly, only 3–16% of the microglia in cortex, hippocampus, cer-
ebellum, and brainstem expressed GFP in the absence of PrPSc at
150 dpi in wt3ko and ko3ko mice (Fig. 3), indicating that
microglia engraftment was consecutive to prion neuropathology
and unrelated to the procedure of BMT.With the onset of clinical
signs of scrapie and the development of spongiform encephalo-
pathic changes in the brain (Fig. 4 I), a strong proliferative re-
sponse involving both BM-derived and endogenous microglia
led to a threefold to fourfold increase in the overall number of
microglial cells in cortex (1440 Iba1 microglia/mm2; 37%
GFP), hippocampus (1123 Iba1 microglia/mm2; 29%
GFP), cerebellum (893 Iba1 microglia/mm2; 61% GFP),
and brainstem (1171 Iba1 microglia/mm2; 54% GFP) (Figs.
2A–C, 3). In contrast, the number of Iba1microglia in wt3ko
mice at 300 dpi was 413/mm2 in cortex (2%GFP), 250/mm2 in
hippocampus (6% GFP), 162/mm2 in cerebellum (18%
GFP), and 187/mm2 in brainstem (16% GFP) (Fig. 3). Simi-
larly, only 6–13% of the microglia in cortex, hippocampus, cer-
ebellum, and brainstem expressedGFP in ko3komice at 300 dpi
(Fig. 3). The number of Iba1 cerebellarmicroglia was decreased
in wt3ko and ko3ko mice at 300 dpi compared with 150 dpi
(Fig. 3). In mice with clinical signs of
scrapie, GFP-positive microglia were
prominent at sites of astrogliosis (Fig.
2E,G) and expressed the proliferation
marker, Tec3 (Fig. 4E). Many of the cells
were activated as demonstrated by their
MHC class II immunoreactivity (Fig. 4A–
D). In the cerebellum, binucleate GFP-
expressing Purkinje cells (Fig. 4 J–L) were
frequently detected in mice with scrapie.
Induction of cytokine, chemokine, and
chemokine receptor mRNA expression
in the CNS of BM chimeras after
peripheral prion inoculation
TaqMan analysis of proinflammatory cy-
tokine, chemokine, and chemokine recep-
tor gene expression was performed to un-
ravel the molecular mediators involved in
microglia recruitment during the course
of scrapie. Expression analysis of proin-
flammatory cytokines in the CNS of
wt3wt mice failed to demonstrate up-
regulation of TNF or IFN- mRNA ex-
pression at 100 dpi when compared with 0
dpi (data not shown). However, TNF and
IFN-mRNA expression increased three-
fold to fourfold at 150 dpi compared with
100 or 0 dpi (wt3wt mice). In terminal
wt3wt mice, TNFmRNA expression fur-
ther increased to 16-fold over control,
whereas IFN- mRNA remained at levels
comparable with 150 dpi. In contrast,
wt3ko or ko3ko mice did not demon-
strate any upregulation of TNF or IFN-
mRNA at 150 dpi. We also investigated
mediators likely to be responsible for the
engraftment of BM-derived microglia in
the CNS. Notably, fractalkine (CX3CL1)
and the chemokine receptor CCR1 were already upregulated
twofold at 100 dpi in wt3wt mice, and fourfold at 150 dpi when
comparedwith 0 dpi inwt3wtmice and 150 dpi inwt3komice.
Interestingly, although unaltered at 100 dpi in wt3wt mice,
CCR5 and its ligand, RANTES, were upregulated threefold to
fourfold at 150 dpi when compared with wt3ko and ko3ko
mice at 150 dpi. In terminal wt3wt mice, expression levels of
CCR1, CCR5, and RANTES mRNA did not increase further be-
yond those at 150 dpi in wt3wt mice. Finally, no induction of
CXCL2 (GRO-), CXCL9 (MIG), CXCL10 (IP-10), and CCL2
(MCP-1) mRNA expression was detected at any time point after
peripheral prion inoculation in the brains of wt3wt, wt3ko, or
ko3ko mice. As a positive control, splenic cDNA derived from
wild-type mice was analyzed, revealing amplification of CCL2,
CXCL9, CXCL10 transcripts, which were not detected in brain.
Engraftment of PrP-expressing bone marrow-derived cells
promotes prion replication in spleen, but not brain of
Prnpo/omice
To evaluate the level of PrP expression in microglial cells, we
performed immunoaffinity assays and immunoblot analysis on
brain homogenates and glial cell lysates. Low levels of PrP expres-
sion were detected in primary cultures of murine microglial cells
and in the immortalized murine microglial cell line, BV-2 (Fig.
Figure 4. Characterization of BM-derived cells in the scrapie-affected brain. Representative images taken from the cerebellum
of a terminally ill ko3wt mouse. A, A GFP-expressing microglial cell is immunoreactive for MHC class II (red), whereas a neigh-
boring GFP cell does not express MHCII (overlay of GFP and Texas Red fluorescence). B, Single optical section through GFP-
expressingmicroglia,which showMHCII immunoreactivity (C).D, Theoverlayof the confocalmicroscopic images inBandC reveals
coexpression of GFP and MHCII. E, A proliferating GFP-expressing microglia shows nuclear Tec3 immunoreactivity (red). Neigh-
boring BM-derivedmicroglia do not express the proliferationmarker (overlay of GFP and Texas Red fluorescence). F, G, Immuno-
histochemical staining for IgG visualized by diaminobenzidine, and counterstaining with hematoxylin reveals the absence of IgG
extravasation into the neuropil (negative control is shown in F ).H, I, Hematoxylin and eosin stainings of cerebellar sections from
wt3wtmice at 0 dpi (H ) and terminal disease (I ). Note the spongiform encephalopathy in I (a highermagnification is shown as
an inset). J, Single optical section throughaGFP-expressingPurkinje cell,which is surroundedbyGFPmicroglia.K, DAPI staining
of thenuclei. L, Theoverlay of the confocalmicroscopic images in J andK reveals that theGFP-expressingPurkinje cell contains two
nuclei (indicated by arrowheads), which is suggestive of cell fusion. A highermagnification of the perikaryon is shown as an inset.
Scale bars: A–D, 10m; E, 5m; F, G, 20m; H, I, 100m; (in L) J–L, 50m.
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5D). At 150 dpi, BM-derived microglia/
macrophages were the only cells in the
brains of wt3ko mice in which PrP im-
munoreactivity could be detected (Fig.
5B). In scrapie, widespread deposition of
PrP was observed in cerebellar microglia
(Fig. 5C).
Because the engraftment of BM-
derived cells was also high in cerebellum
(Fig. 3), we quantified infectivity of cere-
bella and spleens from chimeric mice by
mouse bioassay. All tga20mice developed
scrapie when inoculated intracerebrally
with cerebellum homogenates from
wt3wt and ko3wt chimeras killed be-
yond 150 dpi, but not at 50 or 100 dpi (Fig.
6). A trend toward longer incubation
times was observed in tga20 mice chal-
lenged with cerebellum homogenates
from ko3wt mice, and the brains of
ko3wt mice also contained less PrPSc at
150 dpi compared with wt3wt brains
(Figs. 5A, 6). In contrast, none of the tga20
mice inoculated intracerebrally with cere-
bellum homogenates from wt3ko and
ko3ko chimeras killed at 300 dpi devel-
oped scrapie when allowed to survive
190 d (Fig. 6).
To confirm that reconstitution with wt
BM cells restored prion replication in the
spleens of Prnpo/o mice, we transmitted
spleen homogenates from BM chimeras
after intraperitoneal prion challenge into
tga20 mice. Although the spleens of
wt3ko chimeras were highly infectious
(	5.4 log LD50/ml of homogenate), none
of the tga20 mice inoculated with spleen
homogenates from ko3ko chimeras at
300 dpi developed disease after 180 d
(Fig. 6).
Discussion
Formany years,microglia were thought to
be essentially sessile and to undergo only
minor exchanges with peripheral mono-
cyte–macrophage compartments (Hickey and Kimura, 1988;
Lassmann et al., 1993). However, the present data indicate that
microglia are extensively recruited from bone marrow to brain
during the incubation period of scrapie. The BM-derived micro-
glia appear to replace endogenousmicroglial cells throughout the
brain at the time of PrPSc deposition and before clinical disease
onset.
Microglia engraftment in scrapie
Microglia are the primary immune effector cells in the brain
(Kreutzberg, 1996). They continuously survey their microenvi-
ronment with motile processes and protrusions, and constitute
the first line of defense against invading pathogens (Nimmerjahn
et al., 2005). Using GFP-marked BM chimeric mice, we find that
resident microglia are replaced with BM-derived microglia at the
time of PrPSc deposition in the brain. On average, 54% of micro-
glia expressed GFP, whereas the absolute number of microglia
remained unchanged when PrPSc appeared in the brain. This
substantial engraftment of BM-derived microglial cells may have
gone undetected in the past because it could only be visualized by
genetic labeling of hematopoietic stem cells. Also, it appears to be
unrelated to the procedure of BMT because no increase in the
percentage of GFP-expressing microglia was observed in the
brains of scrapie-inoculatedwt3ko and ko3ko chimeras. Inter-
estingly, the number of microglia decreased with age in cerebel-
lum of wt3ko mice and ko3ko mice, ruling out a long-term
increase in microglia number as a result of lethal irradiation.
These findings are in line with previous studies demonstrating no
change or a decrease in the number of microglia in various re-
gions of the aging mouse brain (Long et al., 1998; Ma et al., 2003;
Radde et al., 2006). Importantly, wt3ko chimeras lacked PrPSc
deposition in the brain and did not develop scrapie despite high
levels of infectivity in the spleens. Because spleen macrophages
were reported to clear inoculum PrPSc and to eliminate newly
synthesized PrPSc in the spleen after intraperitoneal scrapie in-
fection (Michel et al., 1987; Beringue et al., 2000a,b), microglia
Figure 5. Expression of PrP in BM-derived microglia. A, Immunoblot analysis of brain homogenates electrophoresed in the
native state () or after digestionwith proteinase K (PK;). Large amounts of PK-resistant PrP Sc were detected in the brains of
all mice that had developed scrapie (term.): wtmice, andwt3wt and ko3wt chimeras. No PrP Sc accumulationwas detected in
clinically healthy ko mice at 347 dpi, and in wt3wt and ko3wt chimeras at 50 and 100 dpi. Subclinical scrapie was evident in
wt3wt and ko3wtmice at 150 dpi. Note that the amount of PrP Sc was lower in ko3wt compared with wt3wtmice at 150
dpi. B, A GFP-expressing microglial cell (left) is immunoreactive for PrP (middle; Alexa staining) in a wt3ko chimera at 150 dpi
(right; overlay of the images). C, In a wt3wtmouse that had developed scrapie, activated GFP-expressingmicroglia andmacro-
phages (left) show PrP immunoreactivity (middle; Alexa staining). Overlay of the images (right) reveals that BM-derived cells
contain most of the PrP immunoreactivity. D, Immunoblot analysis of brain homogenates and lysates of primary microglial
cultures (MG), BV-2 cells and primary astroglial cultures (Astro). Expression of PrP was comparatively low in microglia and BV-2
cells, requiring immunoaffinity purification (IAP) for detection. Scale bars: B, C, 10m.
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might be involved in the sequestration of disease-associated
prion protein in the brain. In the brainstem of naturally
scrapie-affected sheep, PrP-immunoreactive material was de-
tected in some microglial cells as large perinuclear granules
(Andre´oletti et al., 2002a), which resembles the pattern of PrP
immunoreactivity we observed in BM-derived microglia. Up-
take of PrPSc may be detrimental to microglial cells because
they exhibit tortuous cell processes and occasional intracyto-
plasmic vacuoles in CJD- and scrapie-affected brains (Wil-
liams et al., 1994; von Eitzen et al., 1998). Manipulation of the
cytokine and chemokine systems relevant for microglia re-
cruitment (Cook et al., 2001), or of myeloid proliferation and
recruitment (Heppner et al., 2005; Simard et al., 2006) may
help to clarify whether microglia sequestrate PrPSc, and how
this affects pathogenesis.
Microglia engraftment in other neurodegenerative conditions
Recruitment of myeloid cells into the murine brain and subse-
quent microglial differentiation has been observed, to various
degrees, in a number of neuropathological conditions (Priller et
al., 2001b; Massengale et al., 2005). BM-derived microglia were
found to accumulate in ventralmidbrain and striatum in amouse
model of Parkinson’s disease (Kokovay and Cunningham, 2005)
or in close proximity to damaged neurons during bacterial men-
ingitis (Djukic et al., 2006). Moreover, BM-derived cells contrib-
uted to the recruitment of microglia in response to -amyloid
(A) deposition in amyloid precursor protein (APP)/
presenilin-1 (PS1) double transgenic Alzheimer’s disease (AD)
mice (Malm et al., 2005; Simard et al., 2006). In analogy to our
findings in prion disease, microglia engraftment occurred partic-
ularly during and after the formation ofAdeposits and included
activation of glial cells around the deposits. In APP23 trans-
genic AD mice, up to one-quarter of neocortical amyloid
plaques were associated with BM-derived cells (Stalder et al.,
2005). In conjunction with enhanced infiltration of BM-
derived cells into the hippocampus after lipopolysaccharide
injection, the amount of diffuse A was reduced in APP/PS1
mice (Malm et al., 2005). Importantly, BM-derived microglia
appeared to phagocytose -amyloid in AD transgenic mice,
whereas resident microglia seemed to be rather ineffective in
removing -amyloid (Simard et al., 2006). Microglial activa-
tion was also observed in APP751 transgenic AD mice, which
do not develop plaques but show increased neuronal vulnera-
bility (Koistinaho et al., 2002).
Molecular mediators of microglia recruitment
Microglia are liaisons between the immune system and the ner-
vous system. Although the molecular mediators of microglia en-
graftment at sites of prion pathology are still mostly unknown, a
number of chemokines and cytokines have been implicated in the
disease process. Gene expression studies revealed upregulation of
cathepsin S andC1q complement as a characteristic feature of the
preinflammatory response of monocytes in murine scrapie
(Dandoy-Dron et al., 1998). Fractalkine, which acts as a chemoat-
tractant for microglia, was found to be increased in scrapie
(Hughes et al., 2002). Concomitant with the occurrence of neu-
ronal cell loss, microglia, but not bloodborne perivascular cells
started to express the fractalkine receptor, CX3CR1. Another im-
portant mediator of microglia recruitment in scrapie and CJD
may be CCR5. CCR5 transcripts were increased as early as 100 d
after intracerebral prion inoculation in the SY-rat model of CJD
(Baker et al., 1999). Moreover, the migration rate of retinal mi-
croglia was significantly reduced by a specific CCR5 antagonist
after intravitreal injection of scrapie-infected cell homogenate
(Marella and Chabry, 2004). Finally, PrPSc itself was recently
shown to trigger microglia recruitment in vitro by increasing the
expression level of RANTES in neurons via themitogen-activated
protein kinase signaling pathway (Marella et al., 2005). In line
with these results, we found an upregulation of CCR1, CCR5,
RANTES, and fractalkine mRNA (twofold to fourfold) in the
brains of wt3wt and ko3wt mice at 100–150 dpi (i.e., long
before the appearance of clinical signs of scrapie). The induction
of chemokine and chemokine receptor mRNA was accompanied
by increased gene expression of the proinflammatory cytokines
TNF and IFN-.
In addition, we detected MHC class II antigen expression on
BM-derived microglia in scrapie. Notably, MHC class II-positive
microglia were also found to accumulate during the development
of spongiform changes in the cortex of CJD patients (von Eitzen
et al., 1998).
Absence of prion replication in microglia
One of the most surprising findings of the present study is the
inability of BM-derived microglia to replicate pathological prion
protein. Despite high levels of infectivity in the periphery, 10%
wild-type microglia from wt3ko chimeras failed to infect tga20
mice in bioassays. How can these results be reconciled with the
report that microglial cultures obtained from CJD-infected mice
were as infectious as the starting brain homogenate despite 50-
fold lower expression levels of PrP (Baker et al., 2002)? For one
thing, 5%of the cells in culture were notmicroglia ormonocytes/
macrophages (Baker et al., 2002), and these contaminating cells
may have replicated prions. Also, Baker and colleagues used a
prion strain different from the one we used: it is not impossible
Figure 6. Prion infectivity titers in brains and spleens of chimeric mice after intraperitoneal
prion inoculation. Tga20 indicatormicewere inoculated intracerebrally with 1% (w/v) cerebel-
lum or spleen homogenates from BM-chimeric mice (n 2 per genotype and day postinocu-
lation). Titerswere determined in cerebellum fromwt3wt (red circles), ko3wt (blue circles),
ko3ko (black circles), and wt3ko mice (green circles) at 50, 100, 150, 300 dpi and terminal
disease. Cerebellum infectivity, leading to an attack rate of 100%,was only detected in ko3wt
miceat 150dpi (4.2–5.0 logLD50 /ml),wt3wtmiceat 150dpi (5.1–5.7 logLD50 /ml), terminal
ko3wtmice (5.4 log LD50 /ml), and terminalwt3wtmice (5.2–5.7 log LD50 /ml). Titerswere
alsodetermined in spleens fromko3ko (black triangles) andwt3komice (green triangles) at
300 dpi. Spleen infectivity was only detected in wt3ko mice (5.4 log LD50 /ml).
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that the two strains differ in their cell tropism. The number of
wild-type microglia in our cerebellar transmission experi-
ments was comparatively low. We estimate that 50–100 wild-
type microglia were transplanted. However, the tga20 infectiv-
ity bioassay is able to detect prion infectivity in as low as
107-fold dilutions of a 1% brain homogenate derived from a
terminally sick CD-1 mouse inoculated with RML (Kaeser et
al., 2001). Finally, microglia could have a dual response to
prion infection. Relatively small amounts of prion infectivity,
as they may occur in vivo during extraneural infection and
neuroinvasion, might be taken up and digested by microglia.
In contrast, nonphysiologically large amounts of prions, as in
the case of experimental exposure of cultured microglia to
scrapie-infected brain homogenate, may saturate any “prion
clearance” capacity of microglia and lead to prion replication.
According to the latter hypothesis, the response of microglia
to prions may be dose dependent.
Several previous reports have indicated that infectibility, in-
cubation period, and lesion distribution in scrapie are unaffected
by irradiation and BMT (Williams et al., 1995; Fraser et al., 1996;
Bla¨ttler et al., 1997). The association of reactive microglia with
thin-walled vessels in CJD-infected rat brain suggested entry
(macrophage derivatives) from the bloodstream (Manuelidis et
al., 1997). Interestingly, we found no evidence for BBB impair-
ment in scrapie-inoculated BM chimeric mice at any time point,
which is in line with previous reports excluding BBB leakage in
tga20 and wild-type mice with clinical symptoms of scrapie
(Eikelenboom et al., 1987; Brandner et al., 1998). Magnetic reso-
nance imaging studies of patients with CJD revealed T2-
hyperintensities without significant BBB disruption (Yoon et al.,
1995; Finkenstaedt et al., 1996). However, some studies did re-
port patchy BBB leakage in scrapie (Wisniewski et al., 1983;
Chung et al., 1995), particularly in the cerebellum (Vorbrodt et
al., 1997).
In this study, we demonstrate that BM-derived cells sense
early pathological changes in the brain during the incubation
period of scrapie. Concomitant with the deposition of PrPSc, they
engraft throughout the CNS in substantial numbers as microglia.
Our findings may be relevant to other neurodegenerative disor-
ders involving abnormal protein aggregation, including AD, in
whichBM-derivedmicrogliawere recently shown to phagocytose
-amyloid. Because of their efficient engraftment in host brains,
hematopoietic cellsmay ultimately be exploited for gene therapy-
based delivery of biotherapeutics in prion diseases and other neu-
rodegenerative disorders.
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